Acadia Healthcare Co Lowers FY2025 Adj EPS Guidance from $2.45-$2.65 to $2.35-$2.45 vs $2.48 Est; Lowers FY2025 Sales Guidance from $3.300B-$3.350B to $3.280B-$3.300B vs $3.315B Est
Author: Benzinga Newsdesk | November 05, 2025 04:26pm
Acadia Healthcare Co (NASDAQ:
ACHC) lowers FY2025 Adj EPS guidance from $2.45-$2.65 to $2.35-$2.45 vs $2.48 analyst estimate. Lowers FY2025 sales outlook from $3.300 billion-$3.350 billion to $3.280 billion-$3.300 billion vs $3.315 billion estimate.
Posted In: ACHC